Haiying Cheng
@HaiyingCheng
Followers
148
Following
828
Media
0
Statuses
65
Joined July 2021
Cancer of unknown primary site encompasses a heterogeneous group of metastatic cancers with an unidentified primary site of origin. Putative site-specific therapy and empirical chemotherapy are acceptable treatment options. Read the Clinical Practice article “Cancer of Unknown
6
139
422
Online Now: The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets
4
91
308
Further to below, recent US report of tempus data on smoking vs non smoking related small cell lung cancer, quite different entities https://t.co/9lpt94k77q
#lcsm
Impressive spider plots of PD1-VEGF bispecific BNT327/PM8002 plus first line chemo (left) or 2nd line paclitaxel (R) in ext stage small cell lung cancer. Caveat is SCLC is diff in China, 1/3 of pts never smokers, but nevertheless adds to growing PD1-VEGF bispecific dataset #lcsm
0
6
15
New #JITC review: Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) review https://t.co/kdjAn6BQWk
@mcquadeMDLAc @MarcoRuella @CSpencerPhD @DrBetofMDPhD @BcellBruno
1
38
92
IL-1 signaling in aging and cancer: An inflammaging feedback loop unveiled https://t.co/mjpLHZ1sf1
0
50
220
Join @BalazsHalmosMD, @HaiyingCheng, & @BrendonStilesMD for @gotoPER's New York #LungCancer Symposium. Learn about multidisciplinary treatment, the latest in immunotherapy, & engage in real-world case discussions. FREE for Montefiore staff (DM for code). https://t.co/XAbF0Run0a
0
4
12
Why do some patients benefit less than others from precision cancer medicine? We are excited to share our paper "Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling” out in @NatureComms. https://t.co/e5AYdyrnbx 🧵
5
172
468
🔥Standard and Emerging First-Line Options in EGFR-Mutated NSCLC 🎙️@stephanieplsaw ✅Brief history of EGFR-TKIs ✅Single / Combined approach ✅Plasma EGFRm and co-mutations as biomarker ✅Trial designs ✅How to choose treatment at 1st line #ASCO24 #LCSM @OncoAlert @ASCO
2
69
178
Online Now: Integrated proteogenomic characterization of glioblastoma evolution https://t.co/Xnawb5t556
0
42
115
Phenotypic signatures of circulating neoantigen-reactive CD8+ T cells in patients with metastatic cancers https://t.co/GYjfr3pcYc
3
40
139
Drs. @HaiyingCheng & Matthew Lee found patients treated with #immunotherapy for Non-Small Cell #LungCancer had similar survival, progression-free survival, & treatment duration results—regardless of race, ethnicity, insurance, & income. @EinsteinMed @JNCCN
https://t.co/uKMNV9HZrw
1
4
9
👀💪👏 Looks like our @MontefioreNYC thoracic onc team is on a roll addressing critical questions abt underrepresented pt populations- URM and IO benefit this time around! 🎉 to our new faculty (Monte grad) Matt Lee/ @HaiyingCheng and others!
According to a new @JNCCN study, real world data shows impact of immunotherapy in populations underrepresented in clinical trials. Learn more: https://t.co/CcqqH8xMfO
3
2
18
Great work @HaiyingCheng @ececalidaylan @MontefioreNYC providing key information about an understudied patient population!
Lung cancer significantly contributes to morbidity and mortality among people with HIV. A recently published article in @ClinicalLung analyzes clinicopathological characteristics, including immunotherapy outcomes, for 174 #PWH diagnosed with lung cancer. https://t.co/p5OW8YNvwK
0
8
29
According to a new @JNCCN study, real world data shows impact of immunotherapy in populations underrepresented in clinical trials. Learn more: https://t.co/CcqqH8xMfO
0
3
10
.@HaiyingCheng helped identify RICTOR—a gene amplified in patients with a risk of lung cancer spreading to the brain. With an @AmericanCancer grant, she hopes to determine if targeting RICTOR can treat metastases. #LungCancerAwarenessMonth @EinsteinMed
https://t.co/wBFSC23Nbm
1
7
16
.@HaiyingCheng helped identify RICTOR—a gene amplified in patients with a risk of lung cancer spreading to the brain. With an @AmericanCancer grant, she hopes to determine if targeting RICTOR can treat metastases. #LungCancerAwarenessMonth @EinsteinMed
https://t.co/ogTYtpTCdR
0
3
13
Lung cancer significantly contributes to morbidity and mortality among people with HIV. A recently published article in @ClinicalLung analyzes clinicopathological characteristics, including immunotherapy outcomes, for 174 #PWH diagnosed with lung cancer. https://t.co/p5OW8YNvwK
1
7
23
Online Now: Beyond bacteria: How the intratumor mycobiome modulates lung adenocarcinoma progression
0
30
108
Online Now: Individualized tumor-informed circulating tumor DNA analysis for postoperative monitoring of non-small cell lung cancer
0
24
55
Online Now: PD-L1 and CD58 co-regulated by CMTM6 play yin and yang to shape anti-tumor immunity
cell.com
The CD58-CD2 axis regulates T cell-mediated cancer immunity, but little is known about the regulation of CD58. In two recent papers published in Cancer Cell, Miao et al. and Ho et al. define a...
0
22
51